Elite in Embryonal Tumor with Multilayered Rosettes

Alberto Garaventa

Genoa, IT 
Elite in Embryonal Tumor with Multilayered Rosettes
Genoa, IT 
OverviewLocationsClinical Research

Overview

Alberto Garaventa practices in Genoa, Italy. Mr. Garaventa is rated as an Elite expert by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, Tissue Biopsy, and Nephrectomy.

His clinical research consists of co-authoring 122 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 79 articles and participated in 1 clinical trial in the study of Embryonal Tumor with Multilayered Rosettes.

Gender
Male

Locations

Genoa, Italy
Other Locations
Pisa, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase III Study on Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma.
Phase III Study on Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma.
Enrollment Status: Completed
Publish Date: September 19, 2022
Intervention Type: Drug
Study Drugs: Standard Treatment (as per Protocol ISG SSG III), Intensified Chemotherapy
Study Phase: Phase 3
A Phase I/II Dose Schedule Finding Study of ch14.18/CHO Continuous Infusion Combined With Subcutaneous Aldesleukin (IL-2) in Patients With Primary Refractory or Relapsed Neuroblastoma
A Phase I/II Dose Schedule Finding Study of ch14.18/CHO Continuous Infusion Combined With Subcutaneous Aldesleukin (IL-2) in Patients With Primary Refractory or Relapsed Neuroblastoma
Enrollment Status: Unknown
Publish Date: July 14, 2020
Intervention Type: Drug
Study Drugs: ch14.18/CHO, Aldesleukin, Isotretinoin
Study Phase: Phase 1/Phase 2
Multicentric, Randomized Phase II Trial for the Treatment of Patients With Relapsed Osteosarcoma
Multicentric, Randomized Phase II Trial for the Treatment of Patients With Relapsed Osteosarcoma
Enrollment Status: Terminated
Publish Date: May 13, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

122 Total Publications

Predicting Clinical Deterioration in Pediatric Hematology-Oncology Patients: PEWS Scales-A Scoping Review.
Predicting Clinical Deterioration in Pediatric Hematology-Oncology Patients: PEWS Scales-A Scoping Review.
Journal: Journal of pediatric hematology/oncology nursing
Published: December 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Garaventa's expertise for a condition
ConditionClose
View All 24 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile